project id: TCGA-KIRC; case submitter id: TCGA-DV-A4VX; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.75; rna integrity number: 8.3; age at index: 59; days to birth: -21670; days to death: 1626; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Dead; year of birth: 1949; year of death: 2012; age at diagnosis: 21670; ajcc clinical m: M1; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C64.9; last known disease status: not reported; morphology: 8310/3; primary diagnosis: Clear cell adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; is ffpe: false; composition: Not Reported; days to collection: 1704; days to sample procurement: 0; initial weight: 700.0; portion submitter id: TCGA-DV-A4VX-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 95.0; percent tumor nuclei: 90.0;